Mikhail Sergeevich Zastrozhin

TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels.

TL;DR: In this paper, the authors estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global Burden of Diseases, Injuries, and Risk Factors Study.

TL;DR: Five key insights that are important for health, social, and economic development strategies have been distilled are distilled and are subject to the many limitations outlined in each of the component GBD capstone papers.

TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 5 years of age, with multiple scenarios for child mortality in 2030, were presented in this paper.

TL;DR: Although spending has increased across HIV/AIDS, tuberculosis, and malaria since 2015, spending has not increased in all countries, and outcomes in terms of prevalence, incidence, and per-capita spending have been mixed, suggesting that increases in spending do not always results in improvements in outcomes.